Indies Pharma Jamaica Limited - Laporan Laba Rugi (TTM)

Indies Pharma Jamaica Limited
JM ˙ JMSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Indies Pharma Jamaica Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
10-31
2021
01-31
2021
04-30
2021
07-31
2021
10-31
2022
01-31
2022
04-30
2022
07-31
2022
10-31
2023
01-31
2023
04-30
2023
07-31
2023
10-31
2024
01-31
2024
04-30
2024
07-31
2024
10-31
2025
01-31
2025
04-30
Revenue 766 796 791 833 847 836 884 941 937 981 962 997 1,055 1,069 1,139 1,136 1,159 1,215 1,184
Change (%) 3.89 -0.64 5.41 1.61 -1.33 5.80 6.46 -0.41 4.62 -1.94 3.64 5.91 1.30 6.54 -0.29 2.04 4.87 -2.58
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 254 274 301 319 330 300 288 307 323 348 344 346 417 417 442 464 466 492 470
Change (%) 7.69 9.75 6.14 3.37 -8.90 -4.26 6.70 5.39 7.52 -1.04 0.40 20.80 -0.12 6.04 4.98 0.37 5.64 -4.53
% of Revenue 33.20 34.42 38.02 38.28 38.95 35.96 32.54 32.61 34.51 35.46 35.79 34.67 39.55 38.99 38.81 40.86 40.19 40.49 39.68
Gross Operating Profit 512 522 490 514 517 535 596 634 614 633 617 651 638 652 697 672 693 723 714
Change (%) 2.00 -6.10 4.96 0.52 3.51 11.45 6.35 -3.22 3.10 -2.44 5.44 -1.99 2.23 6.85 -3.63 3.19 4.35 -1.26
% of Revenue 66.80 65.58 61.98 61.72 61.05 64.04 67.46 67.39 65.49 64.54 64.21 65.33 60.45 61.01 61.19 59.14 59.81 59.51 60.32
SG&A 246 230 240 251 244 262 270 276 274 281 300 339 312 342 342 342 355 347 346
Change (%) -6.58 4.42 4.52 -2.67 7.21 3.12 2.07 -0.58 2.60 6.70 12.81 -7.87 9.50 0.12 -0.00 3.81 -2.22 -0.42
% of Revenue 32.15 28.91 30.38 30.13 28.86 31.35 30.56 29.30 29.25 28.68 31.21 33.97 29.55 31.94 30.02 30.11 30.63 28.56 29.19
R&D
Change (%)
% of Revenue
OpEx 549 553 589 616 629 617 613 640 656 688 702 730 785 789 812 843 876 917 894
Change (%) 0.70 6.67 4.57 2.11 -1.98 -0.69 4.39 2.50 4.87 2.11 3.99 7.56 0.50 2.88 3.81 3.92 4.74 -2.49
% of Revenue 71.64 69.44 74.56 73.96 74.33 73.83 69.30 67.96 69.94 70.11 73.01 73.25 74.40 73.81 71.28 74.20 75.57 75.47 75.55
Operating Income 217 243 201 217 217 219 271 302 282 293 260 267 270 280 327 293 283 298 290
Change (%) 11.95 -17.27 7.87 0.19 0.58 24.11 11.13 -6.59 4.04 -11.44 2.69 1.39 3.63 16.83 -10.45 -3.36 5.28 -2.88
% of Revenue 28.36 30.56 25.44 26.04 25.67 26.17 30.70 32.04 30.06 29.89 26.99 26.75 25.60 26.19 28.72 25.80 24.43 24.53 24.45
Interest Expense -10 -25 -41 -61 -69 -68 -68 -62 -60 -62 -63 -65 -67 -64 -62 -60 -64 -65 -66
Change (%) 159.35 60.81 50.68 12.24 -0.72 -0.94 -8.07 -2.99 2.51 2.21 2.26 3.06 -3.59 -3.50 -3.89 7.94 1.14 1.33
% of Revenue -1.28 -3.19 -5.16 -7.37 -8.14 -8.19 -7.67 -6.62 -6.45 -6.32 -6.59 -6.50 -6.33 -6.02 -5.45 -5.26 -5.56 -5.36 -5.58
Net Income 207 215 159 152 168 171 222 252 221 230 194 206 218 221 263 222 252 263 256
Change (%) 3.48 -25.92 -4.28 10.33 1.60 29.88 13.76 -12.38 3.99 -15.33 6.11 5.50 1.59 18.92 -15.45 13.26 4.65 -2.82
% of Revenue 27.07 26.96 20.10 18.26 19.82 20.41 25.06 26.77 23.56 23.41 20.22 20.70 20.62 20.68 23.08 19.57 21.72 21.68 21.62

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista